Deal for Kelonia Therapeutics could come as soon as Monday.

After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...

Strong demand for GLP-1 drugs and next-gen diagnostic testing is pulling investors back into life sciences, even as AI soaks ...

Mesoblast Limited (NASDAQ:MESO) is one of the best low priced biotech stocks to invest in. Mesoblast Limited (NASDAQ:MESO) announced on April 14 that it has acquired an exclusive worldwide license to ...

A slow start to 2026 has put first-time biotech financings on course for their worst year since before the pandemic, reducing ...

The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...

Vertex Pharmaceuticals ( VRTX +1.27%) and Mirum Pharmaceuticals ( MIRM +2.18%) are two biotech stocks that share the same ...

Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimental drugs ...

Seaport Therapeutics, a Boston biotech led by Daphne Zohar, has filed to go public, setting up a Nasdaq debut that could funnel fresh cash into its neuropsychiatric drug pipeline. Spun out of PureTech ...

Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

From the Capital of France to the Capital of New York — a cutting-edge biotech firm that uses AI to research cancer ...